Ultrafine particles affect the balance of endogenous pro- and anti-inflammatory lipid mediators in the lung: in-vitro and in-vivo studies

被引:32
作者
Beck-Speier, Ingrid [4 ]
Karg, Erwin [4 ,5 ]
Behrendt, Heidrun [1 ,2 ,3 ]
Stoeger, Tobias [4 ]
Alessandrini, Francesca [1 ,2 ,3 ,6 ]
机构
[1] Tech Univ Munich, Inst Allergy Res,ZAUM Ctr Allergy & Environm, Helmholtz Zentrum,Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Neuherberg, Germany
[2] Tech Univ Munich, Inst Allergy Res,ZAUM Ctr Allergy & Environm, Helmholtz Zentrum,Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Munich, Germany
[3] Christine Kuehne Ctr Allergy Res & Educ CK CARE, Munich, Germany
[4] German Res Ctr Environm Hlth, Comprehens Pneumol Ctr, Inst Lung Biol & Dis, Helmholtz Zentrum Munchen, Neuherberg, Germany
[5] German Res Ctr Environm Hlth, Cooperat Grp, Comprehens Mol Analyt CMA, Helmholtz Zentrum Munchen, Neuherberg, Germany
[6] German Res Ctr Environm Hlth GmbH, Focus Network Nanoparticles & Hlth NanoHlth, Helmholtz Zentrum Munchen, Neuherberg, Germany
来源
PARTICLE AND FIBRE TOXICOLOGY | 2012年 / 9卷
关键词
Lipid mediators; Particulate matter; Inflammation; Allergy; PARTICULATE AIR-POLLUTION; PROSTAGLANDIN E-2; OXIDATIVE STRESS; ALVEOLAR MACROPHAGES; LEUKOTRIENE B-4; LIPOXIN A(4); INFLAMMATION; RESOLUTION; SIZE; GENERATION;
D O I
10.1186/1743-8977-9-27
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Background: Exposure to ultrafine particles exerts diverse harmful effects including aggravation of pulmonary diseases like asthma. Recently we demonstrated in a mouse model for allergic airway inflammation that particle-derived oxidative stress plays a crucial role during augmentation of allergen-induced lung inflammation by ultrafine carbon particle (UfCP) inhalation. The mechanisms how particle inhalation might change the inflammatory balance in the lungs, leading to accelerated inflammatory reactions, remain unclear. Lipid mediators, known to be immediately generated in response to tissue injury, might be strong candidates for priming this particle-triggered change of the inflammatory balance. Methods: We hypothesize that inhalation of UfCP may disturb the balance of pro- and anti-inflammatory lipid mediators in: i) a model for acute allergic pulmonary inflammation, exposing mice for 24 h before allergen challenge to UfCP inhalation (51.7 nm, 507 mu g/m(3)), and ii) an in-vitro model with primary rat alveolar macrophages (AM) incubated with UfCP (10 mu g/1 x 10(6) cells/ml) for 1 h. Lungs and AM were analysed for pro- and anti-inflammatory lipid mediators, namely leukotriene B-4 (LTB4), prostaglandin E-2 (PGE(2)), 15(S)-hydroxy-eicosatetraenoic acid (15(S)-HETE), lipoxin A(4) (LXA(4)) and oxidative stress marker 8-isoprostane by enzyme immunoassays and immunohistochemistry. Results: In non-sensitized mice UfCP exposure induced a light non-significant increase of all lipid mediators. Similarly but significantly in rat AM all lipid mediators were induced already within 1 h of UfCP stimulation. Also sensitized and challenge mice exposed to filtered air showed a partially significant increase in all lipid mediators. In sensitized and challenged mice UfCP exposure induced highest significant levels of all lipid mediators in the lungs together with the peak of allergic airway inflammation on day 7 after UfCP inhalation. The levels of LTB4, 8-isoprostane and PGE(2) were significantly increased also one day after UfCP exposure. Immunohistochemistry localized highest concentrations of PGE(2) especially in AM one day after UfCP exposure. Conclusion: Our results suggest that UfCP exposure affects the balance between pro-and anti-inflammatory lipid mediators. In allergic mice, where the endogenous balance of pro- and anti-inflammatory mediators is already altered, UfCP exposure aggravates the inflammation and the increase in anti-inflammatory, pro-resolving lipid mediators is insufficient to counterbalance the extensive inflammatory response. This may be a contributing mechanism that explains the increased susceptibility of asthmatic patients towards particle exposure.
引用
收藏
页数:13
相关论文
共 51 条
[21]   Prostaglandins as modulators of immunity [J].
Harris, SG ;
Padilla, J ;
Koumas, L ;
Ray, D ;
Phipps, RP .
TRENDS IN IMMUNOLOGY, 2002, 23 (03) :144-150
[22]   Endogenous lipid mediators in the resolution of airway inflammation [J].
Haworth, O. ;
Levy, B. D. .
EUROPEAN RESPIRATORY JOURNAL, 2007, 30 (05) :980-992
[23]   Combustion aerosols: Factors governing their size and composition and implications to human health [J].
Helble, JJ ;
DeVito, MS ;
Wu, CY ;
Smith, FL ;
Marrack, D .
JOURNAL OF THE AIR & WASTE MANAGEMENT ASSOCIATION, 2000, 50 (09) :1619-1622
[24]   A role for cysteinyl leukotrienes in airway remodeling in a mouse asthma model [J].
Henderson, WR ;
Tang, LO ;
Chu, SJ ;
Tsao, SM ;
Chiang, GKS ;
Jones, F ;
Jonas, M ;
Pae, C ;
Wang, HJ ;
Chi, EY .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 165 (01) :108-116
[25]   Treatment strategies for allergy and asthma [J].
Holgate, Stephen T. ;
Polosao, Riccardo .
NATURE REVIEWS IMMUNOLOGY, 2008, 8 (03) :218-230
[26]  
Holgate Stephen T., 2003, Journal of Allergy and Clinical Immunology, V111, pS18, DOI 10.1067/mai.2003.25
[27]   The leukotriene B4 lipid chemoattractant receptor BLT1 defines antigen-primed T cells in humans [J].
Islam, SA ;
Thomas, SY ;
Hess, C ;
Medoff, BD ;
Means, TK ;
Brander, C ;
Lilly, CM ;
Tager, AM ;
Luster, AD .
BLOOD, 2006, 107 (02) :444-453
[28]   Resolvins and protectins: mediating solutions to inflammation [J].
Kohli, Payal ;
Levy, Bruce D. .
BRITISH JOURNAL OF PHARMACOLOGY, 2009, 158 (04) :960-971
[29]   Ultrafine particle-lung interactions:: Does size matter? [J].
Kreyling, WG ;
Semmler-Behnke, M ;
Möller, W .
JOURNAL OF AEROSOL MEDICINE-DEPOSITION CLEARANCE AND EFFECTS IN THE LUNG, 2006, 19 (01) :74-83
[30]   Diminished lipoxin biosynthesis in severe asthma [J].
Levy, BD ;
Bonnans, C ;
Silverman, ES ;
Palmer, LJ ;
Marigowda, G ;
Israel, E .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2005, 172 (07) :824-830